The data highlight 1 as a multifunctional Ru(II)-based agent with promising DNA/HSA affinity, antioxidant potential, and selective cytotoxicity toward MDR cancer cell lines, warranting further pharmacological evaluation. The gene discussed is ALB; the disease is cancer.